REFERENCES
1. Schwartz V. Ya. Adipose tissue inflammation. Problemy endokrinologii [Problems of Endocrinology]. 2009; 55 (6): 40-5. (in Russian)
2. Schwartz V. Ya. Adipose tissue inflammation. Problemy endokrinologii [Problems of Endocrinology]. 2009; 55 (5): 43-8. (in Russian)
3. Schwartz V. Ya. Adipose tissue inflammation. Problemy endokrinologii [Problems of Endocrinology]. 2009; 55 (4): 44-9. (in Russian)
4. Cutolo M. Estrogen metabolites: increasing evidence for their role in rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol. 2004; 31 (3): 419-21.
5. Castagnetta L. A., Carruba G., Granata O. M., et al. Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis. J Rheumatol. 2003; 30 (12): 2597-605.
6. Abdulkadirova F. R., Ametov A. S., Doskina E. V., et al. The role of lipotoxicity in the pathogenesis of type 2 diabetes mellitus and obesityю. Ozhirenie i metabolism [Obesity and Metabolism]. 2014; 11 (2): 8-12. (in Russian)
7. Kanakis G. A., Nordkap L., Bang A. K., et al. EAA clinical practice guidelines-gynecomastia evaluation and management. Andrology. 2019; 7 (6): 778-93. DOI: https://doi.org/10.1111/andr.12636
8. Kamalov A. A., Pavlova Z. Sh., Gostry A. V., et al. Estrogen metabolites and their pathogenetic role in prostate cancer (review). Tekhnologii zhivykh sistem [Living Systems Technologies]. 2016; 3 (1): 1-9. (in Russian)
9. Pavlova Z. Sh., Kamalov A. A., Golodnikov I. I. Male Hyperestro-genism. Artificial problem or existing reality? Are aromatase inhibitors effective and safe? Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training]. 2020; 9 (4): 47-58. DOI: https://doi.org/10.33029/2304-9529-2020-9-4-47-58 (in Russian)
10. Jankowska E. A., Rozentryt P., Ponikowska B., et al. Circulating estradiol and mortality in men with systolic chronic heart failure. JAMA. 2009; 301 (18): 1892-901.
11. Tazhetdinov O. Kh. Features of diagnosis and treatment of infertility in obese men and overweight: Diss. Moscow, 2012. (in Russian)
12. Cavallini G., Beretta G., Biagiotti G. Preliminary study of letrozole use for improving spermatogenesis in non-obstructive azoospermia patients with normal serum FSH. Asian J Androl. 2011; 13 (6): 895-7. DOI: https://doi.org/10.1038/aja.2011.44
13. Shoshany O., Abhyankar N., Mufarreh N., et al. Outcomes of anastro-zole in oligozoospermic hypoandrogenic subfertile men. Fertil Steril. 2017; 107 (3): 589-94. DOI: https://doi.org/10.1016/j.fertnstert.2016.11.021
14. Saylam B., Efesoy O., Cayan S. The effect of aromatase inhibitor letrozole on body mass index, serum hormones, and sperm parameters in infertile men. Fertil Steril. 2011; 95 (2): 809-11. DOI: https://doi.org/10.1016/j.fertnstert.2010.09.021
15. Basu A., Seth S., Arora K., et al. Evaluating estradiol levels in male patients with colorectal carcinoma. J Clin Diagn Res. 2015; 9 (1): BS 08-10.
16. Montgomery R. B., Mostaghel E. A., Vessella R., et al. Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth. Cancer Res. 2008; 68 (11): 4447-54.
17. Rubinow K. B. Estrogens and body weight regulation in men. Adv Exp Med Biol. 2017; 1043: 285-313.
18. Estradiol, serum. Mayo Clinic Laboratories. URL: https://www.may-ocliniclabs.com/test-catalog/Clinical+and+Interpretive/81816
19. Chadid S., Barber J. R., Rohrmann S., et al. Age-specific serum total and free estradiol concentrations in healthy men in US nationally representative samples. J Endocr Soc. 2019; 3 (10): 1825-36.
20. Schneider G., Kirschner M., Berkowitz R., et al. Increased estrogen production in obese men. J Clin Endocrinol Metab. 1979; 48: 633-8.
21. MacDonald A., Herbison G., Showell M., et al. The impact of body mass index on semen parameters and reproductive hormones in human males: a systematic review with meta-analysis. Hum Reprod Update. 2010; 16 (3): 293-311.
22. Armamento-Villareal R., Aguirre L., Qualls C., et al. Effect of lifestyle intervention on the hormonal profile of frail, obese older men. J Nutr Health Aging. 2016; 20 (3): 334-40.
23. Corona G., Rastrelli G., Monami M., et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol. 2013; 168 (6): 829-43.
24. Mihalca R., Fica S. The impact of obesity on the male reproductive axis. J Med Life. 2014; 7 (2): 296-300.
25. Pellitero S., Olaizola I., Alastrue A., et al. Hypogonadotropic hypogonadism in morbidly obese males is reversed after bariatric surgery. Obes Surg. 2012; 22 (12): 1835-42.